https://www.selleckchem.com/pr....oducts/Deforolimus.h
Fatigue during chemotherapy was mostly affected by the level of fatigue before the start of chemotherapy (B= 0.41; P .001). Patients with G-CSF application in the preceding cycle showed an increased fatigue score (B= 5.43; P= .02). We showed that fatigue during adjuvant chemotherapy was mostly affected by the level of fatigue present before the start of chemotherapy. This result suggests that the level of fatigue before the start of treatment should be included as an important factor when deciding on type and toxicity of chemoth
Beğen
Yorum Yap
Paylaş
